LAG3 and acute myeloid leukemia: Under these conditions, we found that CD33-CAR-T cells from AML patients presented a more exhausted phenotype, with increased PD1 and LAG3 expression, and a decreased proliferation potential that was statistically significant (Figures 3C, D, S4).